MSB 3.76% $1.03 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-410

  1. 429 Posts.
    lightbulb Created with Sketch. 71
    We should assume nothing in this instance since many politicians and families have their own agendas. Yes I agree he will run with it like crazy just like with Remdesivir.

    That aside, I am seeing conflicting comments.
    Are we saying that FDA approval is on the 13th ?
    I have interpreted it as yes they will commence the review on 13th, with no suggestion that it will be approved on the same day.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.